pH-Sensitive liposome retaining Fe-porphyrin as SOD mimic for novel anticancer drug delivery system

Polymers for Advanced Technologies

Volumn 18, Issue 1, 2007, Pages 82-87

  Kawakami, Hiroyoshi ^a   Hiraka, Kazue ^a   Tamai, Miho ^a   Horiuchi, Aiko ^b   Ogata, Akihiko ^b   Hatsugai, Tomomi ^b   Yamaguchi, Aritomo ^b   Oyaizu, Kenichi ^b   Yuasa, Makoto ^b  

^a TOKYO METROPOLITAN UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Drug delivery systems; Fe porphyrin; Nanoparticles; pH Sensitive liposome

Indexed keywords

CONTROLLED DRUG DELIVERY; NEGATIVE IONS; ONCOLOGY; PHOSPHOLIPIDS; POSITIVE IONS;

CYTOTOXICITY; PH-SENSITIVE LIPOSOME; SUPEROXIDE DISMUTASE;

PORPHYRINS;

CONTROLLED DRUG DELIVERY; NEGATIVE IONS; ONCOLOGY; PHOSPHOLIPIDS; PORPHYRINS; POSITIVE IONS;

DRUG DELIVERY; IRON; LIPOSOME; PARTICLE; PH; TOXICITY;

EID: 33846671782     PISSN: 10427147     EISSN: 10991581     Source Type: Journal    
DOI: 10.1002/pat.855     Document Type: Article

References (21)

1. Hafez IM, Ansell S, Cullis PR. Tunable pH-sensitive liposomers composed of mixtures of cationic and anionic lipids. Biophys. J. 2000; 79: 1438-1446.
2. Shi G, Guo W, Stephenson SM, Lee RJ. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J. Control. Release 2002; 80: 309-319.
3. Maeda H, Sawa T, Kouno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release 2001; 74: 47-61.
4. Dougherty TJ, Grindery GB, Weishaupt KR, Boyle DG. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J. Natl. Cancer Inst. 1975; 55: 115-121.
5. Mar P, Levy JG. Stress protein expression in murine tumor cells following photodynamic therapy with benzoporphyrin derivative. Photochem. Photobiol. 1993; 58: 374-379.
6. Ohse T, Nagaoka S, Arakawa Y, Kawakami H, Nakamura K. Cell death by reactive oxygen species generated from water-soluble cationic metalloporphyrins as superoxide dismutase mimics. J. Inorg. Biochem. 2001; 85: 201-208.
7. Kasugai N, Murase T, Ohse T, Nagaoka S, Kawakami H, Kubota S. Selective cell death by water-soluble Fe-porphyrins with superoxide dismutase (SOD) activity. J. Inorg. Biochem. 2002; 91: 349-355.
8. Tisdale MJ, Mahmoud MB. Activities of free radical metabolizing enzymes in tumours. Br. J. Cancer 1983; 47: 809-812.
9. Ueta E, Yoneda K, Yamamoto T. Manganese superoxide dismutase negatively regulates the induction of apoptosis by 5-fluorouracil, peplomycin and γ-rays in squamous cell carcinoma cells. Jpn J. Cancer Res. 1999; 90: 555-564.
10. Kazzaz JA, Xu J, Palaia T, Mantell L, Fein AM, Horowitz S. Cellular oxygen toxicity. J. Biol. Chem. 1996; 271: 15182-15186.
11. Cardoso SM, Pereira C, Oliveira CR. The protective effect of vitamin E, idebenone and reduced glutathione on free radical mediated injury in rat brain synaptosomes. Biochem. Biophys. Res. Commun. 1998; 246: 703-710.
12. Meijer C, Mulder NH, Timmer-Bosscha H, Zijlstra JG, De Vires EGE. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line. Cancer Res. 1989; 47: 1671-1675.
13. Shulyakovskaya T, Sumegi L, Gal D. In vivo experimental studies on the role of free radicals in photodynamic therapy. I. Measurement of the steady state concentration of free radicals in tumor tissues of mice. Biochem. Biophys. Res. Commun. 1993; 95: 581-587.
14. Asayama S, Kasugai N, Nagaoka S, Kubota S, Kawakami H. Superoxide dismutase as a target enzyme for Fe-porphyrin-induced cell death. J. Inorg. Biochem. 2006; in press.
15. Lui F, Lui D. Long-circulating (oil-in-water) as carrier for lipophilic drug. Pharm. Res. 1995; 12: 1060-1064.
16. Managit C, Kawakami M, Nishikawa M, Yamashita F, Hashida M. Targetd and sustained drug delivery using PEGylated galactosylated liposomes. Inter. J. Pharm. 2003; 266: 77-84.
17. Batini-Haberle I, Spasojevi I, Hambright P, Benov L, Crumbliss AL, Fridovich I. Relationship among redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vivo and in vitro superoxide dismutating activities of manganese(III) and iron(III) water-soluble porphyrins. Inorg. Chem. 1999; 38: 4011-4022.
18. Yuasa M, Oyaizu K, Horiuchi A, Ogata A, Hatsugai T, Yamaguchi A, Kawakami H. Liposomal surface-loading of water-soluble cationic iron(III) porphyrins as anticancer drugs. Mol. Pharm. 2004; 1: 387-389.
19. Ohse T, Kawakami H, Morita A, Nagaoka S. Mn-porphyrin derivatives as an antioxidant for medical devices. J. Biomater. Sci. Polym. Edn. 1999; 10: 917-929.
20. Riley DP, Rivers WJ, Weiss RH. Stopped-flow kinetic analysis for monitoring superoxide decay in aqueous systems. Anal. Biochem. 1992; 196: 344-349.
21. Mark SS, Lee J, Groves JT. Peroxynitrite rapidly permeates phospholipids membranes. Proc. Natl. Acad. Sci. USA 1997; 94: 14243-14248.